Margaret Foti: Our heartfelt gratitude to Pfizer for its generous and impactful gift in support of our mission

Margaret Foti made the following post on Twitter:

“On behalf of AACR, I want to extend our heartfelt gratitude to Pfizer for its generous and impactful gift in support of our mission. We are absolutely delighted that AACR has been chosen because of our sustained innovation in cancer research.

This significant donation will further advance cutting-edge science and catapult the development of lifesaving discoveries against cancer.”

For details click here.
Source: Margaret Foti/Twitter

Margaret Foti is the CEO of the American Association for Cancer Research (AACR). Under her leadership, AACR membership has grown from about 3,000 members to over 54,000 in 131 countries and territories, and the AACR’s portfolio of peer-reviewed scientific journals has increased from one to ten. After beginning her AACR career in an editorial position with the journal Cancer Research, Foti progressed through several key editorial and management roles in scientific publishing to become chief executive officer. A graduate of Temple University, Foti is one of the most influential voices in advancing the field of cancer research, both in the United States and abroad. Dr. Foti was elected president of three professional societies in scholarly publishing and in cancer research. She received numerous awards and distinctions, among them honorary degrees from the University of Rome La Sapienza, the University of Catania in Sicily and the University CEU of San Pablo in Madrid, Tara Withington Public Service Award from the Society for Immunotherapy of Cancer (SITC), 2018 Women for Oncology Award from the European Society for Medical Oncology, the 2016 James Ewing Layperson’s Award from the Society of Surgical Oncology. In 2007, the AACR established the first AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research, which is given annually in her name.